JY
LYRA

Jeff Yass’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Jeff Yass’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-926
Closed -$13K – 12583
2024
Q2 		$13K Sell
926
-82
-8% -$9.27K ﹤0.01% 11739
2024
Q1 		$313K Buy
+1,008
New +$269K ﹤0.01% 9615
2023
Q1 		– Sell
-234
Closed -$36.7K – 13113
2022
Q4 		$36.7K Sell
234
-28
-11% -$5.54K ﹤0.01% 11553
2022
Q3 		$66K Buy
+262
New +$77.5K ﹤0.01% 12020

Other funds holding LYRA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jeff Yass's LYRA Position: Q2 2025 in Review

Jeff Yass sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 4,351 shares — an estimated $27.5K sold.

Jeff Yass first reported a position in LYRA in Q2 2021 and held it in 13 quarters. The position peaked at $2.14M in Q1 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Jeff Yass reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Jeff Yass sold 4,351 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $27.5K.
  • Jeff Yass first reported a position in LYRA THERAPEUTICS INC in Q2 2021 and held it in 13 quarters.
  • Jeff Yass's LYRA THERAPEUTICS INC position peaked at $2.14M in Q1 2024.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.